The Center for Genomics and Transcriptomics in Tübingen, Germany has launched next-generation sequencing panels for the diagnosis of ataxia, hereditary spastic paraplegia, spinal muscular atrophy, choreatic movement disorders, and leukodystrophy/leukoencephalopathy.
It has also launched panels for inherited kidney diseases. The comprehensive panel covers 145 genes associated with both isolated and syndromic nephropathies. It can also be run as 21 different subpanels.
Additionally, CeGaT has revised its diagnostic panel for neurodegenerative diseases from 16 to 22 subpanels.